Stay updated on Pembrolizumab Combo in Endometrial Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The site footer’s displayed revision changes from v3.7.2 to v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-03T21:27:32.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    An NIH banner notes a transition in terminology from “Artificial Intelligence” to “Super Intelligence,” and the site revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.3%
    Check dated 2026-10-20T21:41:32.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.0%
    Check dated 2026-10-06T20:52:54.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    A new version (82) appears with a 2026-09-17 date, and the history includes a Study Status entry dated 2026-09-18, representing an update to the trial's current status in the record.
    Difference
    0.2%
    Check dated 2026-09-22T23:00:04.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    A new revision entry v3.7.0 was added to the study record history. The previous revision v3.6.6 was removed, reflecting an update to the page's version history.
    Difference
    0.0%
    Check dated 2026-09-15T21:39:14.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The revision label in the page history changes from v3.6.5 to v3.6.6, indicating a new platform release in the history view.
    Difference
    0.0%
    Check dated 2026-09-01T17:54:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Endometrial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Endometrial Cancer Clinical Trial page.